157 related articles for article (PubMed ID: 26965221)
1. Estimating the extent and economic impact of under and overdiagnosis of chronic obstructive pulmonary disease in primary care.
Spyratos D; Chloros D; Michalopoulou D; Sichletidis L
Chron Respir Dis; 2016 Aug; 13(3):240-6. PubMed ID: 26965221
[TBL] [Abstract][Full Text] [Related]
2. Missed diagnosis and overtreatment of COPD among smoking primary care population in Central Greece: old problems persist.
Stafyla E; Kotsiou OS; Deskata K; Gourgoulianis KI
Int J Chron Obstruct Pulmon Dis; 2018; 13():487-498. PubMed ID: 29440886
[TBL] [Abstract][Full Text] [Related]
3. Adherence to GOLD guideline treatment recommendations among pulmonologists in Turkey.
Sen E; Guclu SZ; Kibar I; Ocal U; Yilmaz V; Celik O; Cimen F; Topcu F; Orhun M; Tereci H; Konya A; Ar I; Saryal S
Int J Chron Obstruct Pulmon Dis; 2015; 10():2657-63. PubMed ID: 26715844
[TBL] [Abstract][Full Text] [Related]
4. Characteristics, disease burden and costs of COPD patients in the two years following initiation of long-acting bronchodilators in UK primary care.
Punekar YS; Landis SH; Wurst K; Le H
Respir Res; 2015 Nov; 16():141. PubMed ID: 26572740
[TBL] [Abstract][Full Text] [Related]
5. The impact of 2011 and 2017 Global Initiative for Chronic Obstructive Pulmonary Disease (GOLD) guidelines on allocation and pharmacological management of patients with COPD in Taiwan: Taiwan Obstructive Lung Disease (TOLD) study.
Hsieh MJ; Huang SY; Yang TM; Tao CW; Cheng SL; Lee CH; Kuo PH; Wu YK; Chen NH; Hsu WH; Hsu JY; Lin MS; Wang CC; Wei YF; Tsai YH
Int J Chron Obstruct Pulmon Dis; 2018; 13():2949-2959. PubMed ID: 30310271
[TBL] [Abstract][Full Text] [Related]
6. Trend of cost and utilization of COPD medication in Korea.
Lee J; Lee JH; Kim JA; Rhee CK
Int J Chron Obstruct Pulmon Dis; 2017; 12():27-33. PubMed ID: 28031708
[TBL] [Abstract][Full Text] [Related]
7. An evaluation of early medication use for COPD: a population-based cohort study.
Falk J; Dik N; Bugden S
Int J Chron Obstruct Pulmon Dis; 2016; 11():3101-3108. PubMed ID: 27994449
[TBL] [Abstract][Full Text] [Related]
8. Switching treatments in COPD: implications for costs and treatment adherence.
Braido F; Lavorini F; Blasi F; Baiardini I; Canonica GW
Int J Chron Obstruct Pulmon Dis; 2015; 10():2601-8. PubMed ID: 26664108
[TBL] [Abstract][Full Text] [Related]
9. Agreement between a simple dyspnea-guided treatment algorithm for stable COPD and the GOLD guidelines: a pilot study.
Cabrera C; Casanova C; Martín Y; Mirabal V; Sánchez Mdel C; Álvarez F; Juliá G; Cabrera-Navarro P; García-Bello MÁ; Marín JM; de-Torres JP; Divo M; Celli B
Int J Chron Obstruct Pulmon Dis; 2016; 11():1217-22. PubMed ID: 27354780
[TBL] [Abstract][Full Text] [Related]
10. Costs of chronic obstructive pulmonary disease in relation to compliance with guidelines: a study in the primary care setting.
Miravitlles M; Sicras A; Crespo C; Cuesta M; Brosa M; Galera J; Lahoz R; Lleonart M; Riera MI
Ther Adv Respir Dis; 2013 Jun; 7(3):139-50. PubMed ID: 23653458
[TBL] [Abstract][Full Text] [Related]
11. Costs of pharmacotherapy of chronic obstructive pulmonary disease in relation to changing Global Initiative for Chronic Obstructive Lung Disease guidelines (2007, 2011, and 2017 updates).
Brożek GM; Nowak M; Zejda JE; Jankowski M; Lawson J; Pierzchała W
Pol Arch Intern Med; 2019 May; 129(5):308-315. PubMed ID: 30867403
[TBL] [Abstract][Full Text] [Related]
12. The pharmacological cost of COPD during Greek economic crisis.
Stafyla E; Kerenidi T; Gerogianni I; Geitona M; Daniil Z; Gourgoulianis KI
Int J Chron Obstruct Pulmon Dis; 2017; 12():461-466. PubMed ID: 28203069
[TBL] [Abstract][Full Text] [Related]
13. Variation in adherence with Global Initiative for Chronic Obstructive Lung Disease (GOLD) drug therapy guidelines: a retrospective actuarial claims data analysis.
Fitch K; Iwasaki K; Pyenson B; Plauschinat C; Zhang J
Curr Med Res Opin; 2011 Jul; 27(7):1425-9. PubMed ID: 21599554
[TBL] [Abstract][Full Text] [Related]
14. Subutilization of COPD guidelines in primary care: a pilot study.
Laniado-Laborín R; Rendón A; Alcantar-Schramm JM; Cazares-Adame R; Bauerle O
J Prim Care Community Health; 2013 Jul; 4(3):172-6. PubMed ID: 23799703
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis and management of chronic obstructive pulmonary disease (COPD) in a primary care clinic.
Chavez PC; Shokar NK
COPD; 2009 Dec; 6(6):446-51. PubMed ID: 19938968
[TBL] [Abstract][Full Text] [Related]
16. The association between inhaled long-acting bronchodilators and less in-hospital care in newly-diagnosed COPD patients.
Kim J; Kim K; Kim Y; Yoo KH; Lee CK; Yoon HK; Kim YS; Park YB; Lee JH; Oh YM; Lee SD; Lee SW
Respir Med; 2014 Jan; 108(1):153-61. PubMed ID: 23993445
[TBL] [Abstract][Full Text] [Related]
17. Underdiagnosis, false diagnosis and treatment of COPD in a selected population in Northern Greece.
Spyratos D; Chloros D; Michalopoulou D; Tsiouprou I; Christoglou K; Sichletidis L
Eur J Gen Pract; 2021 Dec; 27(1):97-102. PubMed ID: 34027790
[TBL] [Abstract][Full Text] [Related]
18. The burden of chronic obstructive pulmonary disease associated with maintenance monotherapy in the UK.
Edwards SC; Fairbrother SE; Scowcroft A; Chiu G; Ternouth A; Lipworth BJ
Int J Chron Obstruct Pulmon Dis; 2016; 11():2851-2858. PubMed ID: 27920512
[TBL] [Abstract][Full Text] [Related]
19. Respiratory pharmacotherapy use in patients newly diagnosed with chronic obstructive pulmonary disease in a primary care setting in the UK: a retrospective cohort study.
Wurst KE; Shukla A; Muellerova H; Davis KJ
COPD; 2014 Sep; 11(5):521-30. PubMed ID: 24945236
[TBL] [Abstract][Full Text] [Related]
20. Health care use and economic burden of patients with diagnosed chronic obstructive pulmonary disease in Korea.
Kim C; Yoo KH; Rhee CK; Yoon HK; Kim YS; Lee SW; Oh YM; Lee SD; Lee JH; Kim KJ; Kim JH; Park YB
Int J Tuberc Lung Dis; 2014 Jun; 18(6):737-43. PubMed ID: 24903947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
